https://www.ajmc.com/watch 0.50 https://www.ajmc.com/peer-exchange/optimizing-treatment-strategies-for-glaucoma-beyond-first-line 2021-12-14 0.50 https://www.ajmc.com/peer-exchange/opportunities-for-biosimilars-a-multidisciplinary-perspective 2023-10-23 0.50 https://www.ajmc.com/peer-exchange/exploring-novel-treatment-options-for-neurofibromatosis-type-1-with-plexiform-neurofibromas 2025-04-30 0.50 https://www.ajmc.com/peer-exchange/the-untold-burden-of-uncomplicated-utis-addressing-recurrence-and-treatment-gaps 2025-05-22 0.50 https://www.ajmc.com/peer-exchange/the-jak-inhibitor-shift-in-vitiligo-a-critical-review-of-clinical-data-and-economic-realities 2026-07-30 0.50 https://www.ajmc.com/peer-exchange/treatment-and-management-of-interstitial-lung-disease-ild 2022-04-06 0.50 https://www.ajmc.com/peer-exchange/expanding-horizons-the-present-and-future-of-bispecific-antibodies-across-oncology 2025-05-22 0.50 https://www.ajmc.com/peer-exchange/utilizing-pathway-directed-therapy-in-multiple-myeloma 2022-12-20 0.50 https://www.ajmc.com/peer-exchange/lp-a-and-cardiovascular-risk-advancing-awareness-testing-and-management-in-clinical-practice 2025-05-22 0.50 https://www.ajmc.com/peer-exchange/advances-in-cdk4-6-inhibitor-use-in-high-risk-early-breast-cancer-2024-updates 2024-07-10 0.50 https://www.ajmc.com/peer-exchange/btk-inhibitors-in-r-r-cll-navigating-options-and-tailoring-treatment 2024-12-20 0.50 https://www.ajmc.com/peer-exchange/evolving-approaches-in-her2-mutant-nsclc-emerging-evidence-and-practical-considerations 2026-01-08 0.50 https://www.ajmc.com/peer-exchange/bridging-the-gap-addressing-unmet-needs-in-spinal-muscular-atrophy-for-older-patients 2025-05-22 0.50 https://www.ajmc.com/peer-exchange/optimizing-metastatic-colorectal-cancer-care 2025-10-20 0.50 https://www.ajmc.com/peer-exchange/access-considerations-for-gene-therapies-among-patients-with-rare-diseases 2024-06-26 0.50 https://www.ajmc.com/peer-exchange/medication-management-considerations-in-copd 2023-03-22 0.50 https://www.ajmc.com/peer-exchange/clinical-and-economic-utility-of-btk-inhibitors-in-cll 2024-06-27 0.50 https://www.ajmc.com/peer-exchange/important-immunotherapy-updates-in-non-small-cell-lung-cancer 2026-02-18 0.50 https://www.ajmc.com/peer-exchange/optimizing-btk-inhibitors-in-cll-and-sll 2023-12-22 0.50 https://www.ajmc.com/peer-exchange/managed-care-perspectives-optimizing-women-s-reproductive-health 2022-05-31 0.50 https://www.ajmc.com/peer-exchange/breaking-the-cycle-unmet-needs-in-mental-health-access-treatments-and-outcomes 2026-06-10 0.50 https://www.ajmc.com/peer-exchange/idiopathic-pulmonary-fibrosis 2025-08-04 0.50 https://www.ajmc.com/peer-exchange/treatment-strategies-in-hepatocellular-carcinoma-hcc-optimizing-outcomes-and-resource-allocation 2023-10-05 0.50 https://www.ajmc.com/peer-exchange/proactive-detection-of-arrhythmia-improving-outcomes-through-predictive-solutions-and-value 2025-08-13 0.50 https://www.ajmc.com/peer-exchange/management-of-treatment-resistant-depression 2022-03-25 0.50 https://www.ajmc.com/peer-exchange/considerations-for-operationalizing-bispecific-antibodies-in-cancer-care 2023-12-06 0.50 https://www.ajmc.com/peer-exchange/strategies-in-managing-cold-agglutinin-disease 2021-09-22 0.50 https://www.ajmc.com/peer-exchange/from-burden-to-better-outcomes-evolving-strategies-in-schizophrenia-care 2025-10-30 0.50 https://www.ajmc.com/peer-exchange/important-updates-in-the-management-of-patients-with-metastatic-colorectal-cancer 2023-09-28 0.50 https://www.ajmc.com/peer-exchange/key-updates-in-the-management-of-small-cell-lung-cancer 2024-09-19 0.50 https://www.ajmc.com/peer-exchange/examining-key-updates-in-first-line-treatment-options-for-multiple-myeloma 2025-06-06 0.50 https://www.ajmc.com/peer-exchange/tailoring-treatment-selection-for-various-stages-of-nsclc-optimizing-patient-outcomes 2023-09-28 0.50 https://www.ajmc.com/peer-exchange/kmt2a-rearranged-aml-aligning-care-guidelines-and-access 2025-06-04 0.50 https://www.ajmc.com/peer-exchange/frontline-insights-in-multiple-myeloma-treatment 2023-12-22 0.50 https://www.ajmc.com/peer-exchange/advances-in-therapy-for-er-her2-metastatic-breast-cancer 2024-05-10 0.50 https://www.ajmc.com/peer-exchange/desmoid-tumors-advancements-and-emerging-therapies 2025-05-22 0.50 https://www.ajmc.com/peer-exchange/advancing-care-in-aml-exploring-novel-treatment-options 2025-09-29 0.50 https://www.ajmc.com/peer-exchange/balancing-care-and-cost-the-evolving-landscape-of-agitation-in-alzheimer-s-disease 2026-07-16 0.50 https://www.ajmc.com/peer-exchange/advancing-care-in-type-2-diabetes-and-obesity-a-coordinated-guideline-driven-approach 2025-06-06 0.50 https://www.ajmc.com/peer-exchange/bridging-the-metabolic-divide-integrating-obesity-and-mash-in-evolving-care-strategies 2025-11-11 0.50 https://www.ajmc.com/peer-exchange/oral-serd-therapy-in-er-her2-metastatic-breast-cancer 2023-06-27 0.50 https://www.ajmc.com/peer-exchange/key-treatment-updates-in-relapsed-refractory-follicular-lymphoma 2025-12-18 0.50 https://www.ajmc.com/peer-exchange/population-health-implications-of-cardiorenal-metabolic-syndrome 2021-08-11 0.50 https://www.ajmc.com/peer-exchange/bruton-tyrosine-kinase-inhibitors-in-patients-with-multiple-sclerosis 2023-06-12 0.50 https://www.ajmc.com/peer-exchange/bispecific-antibodies-in-multiple-myeloma-optimizing-care-across-settings 2025-12-19 0.50 https://www.ajmc.com/peer-exchange/treating-pnh-understanding-complement-inhibitors-modes-of-administration-and-coordinated-patient 2024-06-04 0.50 https://www.ajmc.com/peer-exchange/oral-therapy-considerations-for-the-management-of-myelodysplastic-syndromes-mds- 2021-12-14 0.50 https://www.ajmc.com/peer-exchange/navigating-policy-and-utilization-management-in-oncology-aligning-evidence-with-access 2025-11-06 0.50 https://www.ajmc.com/peer-exchange/navigating-next-generation-serds-in-hr-breast-cancer-insights-for-clinical-decision-making 2026-06-23 0.50 https://www.ajmc.com/peer-exchange/employing-effective-multidisciplinary-care-to-reduce-the-burden-of-myelodysplastic-syndrome 2023-11-13 0.50 https://www.ajmc.com/peer-exchange/strategies-for-supporting-early-diagnosis-and-implementation-of-amyloid-targeting-therapies-in 2025-05-22 0.50 https://www.ajmc.com/peer-exchange/pre-exposure-prophylaxis-prep-for-hiv-improving-access-and-uptake 2021-06-30 0.50 https://www.ajmc.com/peer-exchange/her2-directed-therapies-in-nsclc-navigating-clinical-insights-integration-challenges-and-access 2024-09-30 0.50 https://www.ajmc.com/peer-exchange/a-population-health-approach-to-managing-heart-failure 2022-09-23 0.50 https://www.ajmc.com/peer-exchange/bruton-tyrosine-kinase-inhibitors-in-leukemia-and-lymphoma 2023-01-05 0.50 https://www.ajmc.com/peer-exchange/disease-burden-and-management-of-vitiligo 2022-08-22 0.50 https://www.ajmc.com/peer-exchange/role-of-real-world-evidence-in-the-evolving-treatment-landscape-of-multiple-myeloma 2022-02-18 0.50 https://www.ajmc.com/peer-exchange/exploring-novel-treatment-options-for-chronic-spontaneous-urticaria 2024-06-27 0.50 https://www.ajmc.com/peer-exchange/redefining-menopause-management-addressing-gaps-embracing-innovations-and-enhancing-outcomes 2024-10-29 0.50 https://www.ajmc.com/peer-exchange/advocating-for-earlier-screening-in-chronic-kidney-disease 2025-12-15 0.50 https://www.ajmc.com/peer-exchange/advancing-ischemic-stroke-care-foundations-current-therapies-and-the-emerging-role-of-factor-xia 2026-05-04 0.50 https://www.ajmc.com/peer-exchange/from-evidence-to-implementation-clarifications-around-uspstf-recommendations-for-hiv-pre-exposur 2022-01-11 0.50 https://www.ajmc.com/peer-exchange/exploring-novel-therapies-for-relapsed-refractory-multiple-myeloma 2025-11-11 0.50 https://www.ajmc.com/peer-exchange/important-updates-in-the-management-of-patients-with-heart-failure 2023-10-23 0.50 https://www.ajmc.com/peer-exchange/the-evolving-role-of-subcutaneous-therapies-in-nsclc 2025-10-23 0.50 https://www.ajmc.com/peer-exchange/multiple-myeloma-today-navigating-a-shifting-treatment-landscape 2026-06-09 0.50 https://www.ajmc.com/peer-exchange/elevating-the-role-of-advanced-practice-providers-in-the-evolving-alzheimer-s-disease-landscape 2025-12-16 0.50 https://www.ajmc.com/peer-exchange/therapies-and-preventive-strategies-for-recurrent-clostridium-difficile-infections 2021-11-18 0.50 https://www.ajmc.com/peer-exchange/from-ash-2024-to-practice-implementing-bispecific-therapies-in-b-cell-lymphomas 2024-12-20 0.50 https://www.ajmc.com/peer-exchange/important-updates-in-the-management-of-patients-with-desmoid-tumors 2025-11-13 0.50 https://www.ajmc.com/peer-exchange/managing-patients-with-schizophrenia-provider-and-payer-considerations 2023-06-27 0.50 https://www.ajmc.com/peer-exchange/treating-wet-age-related-macular-degeneration-and-diabetic-macular-edema 2022-02-01 0.50 https://www.ajmc.com/peer-exchange/optimizing-care-for-metastatic-non-small-cell-lung-cancer-without-driver-mutations 2024-06-25 0.50 https://www.ajmc.com/peer-exchange/biosimilars-unveiled-current-trends-challenges-and-future-opportunities-in-the-us-marketplace 2024-07-16 0.50 https://www.ajmc.com/peer-exchange/advancing-alk-nsclc-care-optimizing-treatment-sequencing-and-long-term-outcomes 2025-05-01 0.50 https://www.ajmc.com/peer-exchange/key-considerations-for-the-management-of-rsv-in-adult-patients 2024-06-12 0.50 https://www.ajmc.com/peer-exchange/advancing-ipf-care-new-evidence-and-economic-considerations-in-treatment-decision-making 2025-05-28 0.50 https://www.ajmc.com/peer-exchange/advancing-iga-nephropathy-care-emerging-therapies-unmet-needs-and-economic-considerations 2025-05-22 0.50 https://www.ajmc.com/peer-exchange/optimizing-hiv-treatment 2023-05-30 0.50 https://www.ajmc.com/peer-exchange/emerging-therapies-in-geographic-atrophy 2022-12-23 0.50 https://www.ajmc.com/peer-exchange/the-evolving-treatment-landscape-of-atopic-dermatitis-and-other-dermatological-conditions 2023-04-21 0.50 https://www.ajmc.com/peer-exchange/optimizing-management-of-metastatic-colorectal-cancer-pharmacists-evolving-role-and-overcoming 2025-03-03 0.50 https://www.ajmc.com/peer-exchange/equitable-management-of-atopic-dermatitis-treatment-considerations-across-patient-populations 2025-08-20 0.50 https://www.ajmc.com/peer-exchange/advancing-heart-failure-management-with-novel-therapies-and-system-level-insights 2025-10-13 0.50 https://www.ajmc.com/peer-exchange/optimizing-oncology-workflows-the-shift-from-iv-to-subcutaneous-treatments 2025-06-05 0.50 https://www.ajmc.com/peer-exchange/exploring-novel-treatment-options-for-alopecia-areata 2024-12-11 0.50 https://www.ajmc.com/peer-exchange/advancing-mds-care-navigating-challenges-and-exploring-the-patient-experience 2025-05-22 0.50 https://www.ajmc.com/peer-exchange/practical-insights-for-treating-metastatic-colorectal-cancer-bridging-research-to-real-world 2024-09-11 0.50 https://www.ajmc.com/peer-exchange/the-evolving-treatment-landscape-and-value-based-considerations-for-the-management-of-wet-age 2023-02-09 0.50 https://www.ajmc.com/peer-exchange/immunotherapy-in-nonmelanoma-skin-cancers 2023-11-28 0.50 https://www.ajmc.com/peer-exchange/advancing-precision-medicine-through-comprehensive-genomic-profiling-cgp- 2021-12-21 0.50 https://www.ajmc.com/peer-exchange/a-personalized-approach-to-disease-management-in-psoriasis 2021-11-22 0.50 https://www.ajmc.com/peer-exchange/advancing-care-in-neuroendocrine-carcinomas-from-disease-burden-to-emerging-therapeutic 2026-06-19 0.50 https://www.ajmc.com/peer-exchange/evaluating-different-treatment-options-for-patients-with-bronchiectasis 2025-05-22 0.50 https://www.ajmc.com/peer-exchange/management-of-multidrug-resistant-hiv 2023-03-01 0.50 https://www.ajmc.com/peer-exchange/utilizing-intravenous-iron-injections-to-improve-patient-outcomes 2024-12-19 0.50 https://www.ajmc.com/peer-exchange/examining-novel-treatment-options-for-patients-with-acne-vulgaris 2023-08-03 0.50 https://www.ajmc.com/peer-exchange/generalized-pustular-psoriasis-provider-and-payer-considerations-for-care 2022-12-22 0.50 https://www.ajmc.com/peer-exchange/evolving-role-of-adcs-in-her2-positive-breast-cancer-clinical-integration 2025-12-22 0.50 https://www.ajmc.com/peer-exchange/updates-in-the-management-of-chronic-kidney-disease-and-type-2-diabetes 2021-09-28 0.50 https://www.ajmc.com/peer-exchange/progressing-prescription-software-finding-the-best-path-forward-for-adoption-of-prescription 2024-05-15 0.50 https://www.ajmc.com/peer-exchange/exploring-the-potential-impact-of-rsv-respiratory-syncytial-virus-vaccines-in-adult-population 2023-05-14 0.50 https://www.ajmc.com/peer-exchange/key-issues-in-women-s-reproductive-health 2021-12-20 0.50 https://www.ajmc.com/peer-exchange/bridging-gaps-in-hidradenitis-suppurativa-clinical-insights-for-collaborative-and-comprehensive 2025-07-10 0.50 https://www.ajmc.com/peer-exchange/population-health-management-of-chronic-kidney-disease-ckd 2022-08-09 0.50 https://www.ajmc.com/peer-exchange/cdk-4-6-inhibitors-in-high-risk-early-breast-cancer 2023-06-21 0.50 https://www.ajmc.com/peer-exchange/advances-in-the-treatment-of-alzheimer-disease-current-landscape-and-future-directions 2024-04-30 0.50 https://www.ajmc.com/peer-exchange/navigating-ph-all-management 2023-12-19 0.50 https://www.ajmc.com/peer-exchange/the-economics-of-atopic-dermatitis-from-real-world-burden-to-value-driven-treatment-strategies 2025-09-30 0.50 https://www.ajmc.com/peer-exchange/updates-in-the-management-of-myelodysplastic-syndromes-mds 2022-09-22 0.50 https://www.ajmc.com/peer-exchange/treatment-with-bispecifics-in-relapsed-refractory-multiple-myeloma 2023-04-27 0.50 https://www.ajmc.com/peer-exchange/exploring-the-implementation-of-quality-care-programs-for-patients-with-mpn 2021-05-19 0.50 https://www.ajmc.com/peer-exchange/emerging-treatment-options-in-relapsed-refractory-multiple-myeloma 2021-05-19 0.50 https://www.ajmc.com/peer-exchange/acute-and-preventive-therapy-for-migraine 2021-05-19 0.50 https://www.ajmc.com/peer-exchange/video-series-scheduler-test 2021-06-27 0.50 https://www.ajmc.com/peer-exchange/advances-in-the-treatment-of-hyperhidrosis 2021-08-12 0.50 https://www.ajmc.com/peer-exchange/advances-metastatic-breast-cancer 2021-05-19 0.50 https://www.ajmc.com/peer-exchange/agerelated-macular-degeneration-treatments-determining-appropriate-use 2021-05-19 0.50 https://www.ajmc.com/peer-exchange/asthma-treatment-with-biologics 2022-02-18 0.50 https://www.ajmc.com/peer-exchange/cdk46-inhibitors-in-metastatic-breast-cancer-treatment 2021-05-19 0.50 https://www.ajmc.com/peer-exchange/challenges-sickle-cell-treatment 2021-05-19 0.50 https://www.ajmc.com/peer-exchange/chronic-fibrosing-ild-progressive-phenotype 2021-05-19 0.50 https://www.ajmc.com/peer-exchange/comorbidities-psoriasis-metabolic-syndrome 2021-05-19 0.50 https://www.ajmc.com/peer-exchange/copd-treatment-updates 2021-05-19 0.50 https://www.ajmc.com/peer-exchange/cost-effectiveness-cardiovascular-risk-reduction 2021-05-19 0.50 https://www.ajmc.com/peer-exchange/deeper-understanding-of-wound-care 2021-05-19 0.50 https://www.ajmc.com/peer-exchange/diabetes-and-cardiometabolic-health 2021-05-19 0.50 https://www.ajmc.com/peer-exchange/diabetes-and-obesity-management 2021-05-19 0.50 https://www.ajmc.com/peer-exchange/diabetes-complications 2021-05-19 0.50 https://www.ajmc.com/peer-exchange/diabetes-therapy-and-cardiovascular-outcomes-an-update 2021-05-19 0.50 https://www.ajmc.com/peer-exchange/emerging-treatment-for-migraine 2021-05-19 0.50 https://www.ajmc.com/peer-exchange/finding-value-in-todays-new-insulin 2021-05-19 0.50 https://www.ajmc.com/peer-exchange/healthcare-reform-stakeholders-summit-fall-2015 2021-05-19 0.50 https://www.ajmc.com/peer-exchange/healthcare-reform-stakeholders-summit-spring-2015 2021-05-19 0.50 https://www.ajmc.com/peer-exchange/hepatic-encephalopathy-management 2021-05-19 0.50 https://www.ajmc.com/peer-exchange/identifying-secondary-progressive-multiple-sclerosis 2021-05-19 0.50 https://www.ajmc.com/peer-exchange/immunotherapy 2021-05-19 0.50 https://www.ajmc.com/peer-exchange/immunotherapy-oncology-care-model 2021-05-19 0.50 https://www.ajmc.com/peer-exchange/insomnia-elderly-patients 2021-05-19 0.50 https://www.ajmc.com/peer-exchange/management-optimization-in-atopic-dermatitis 2021-05-19 0.50 https://www.ajmc.com/peer-exchange/neurological-disorders 2021-05-19 0.50 https://www.ajmc.com/peer-exchange/new-classes-for-treatment-of-type-2-diabetes 2021-05-19 0.50 https://www.ajmc.com/peer-exchange/oncology-stakeholder-summit-2014 2021-05-19 0.50 https://www.ajmc.com/peer-exchange/oncology-stakeholder-summit-fall-2015 2021-05-19 0.50 https://www.ajmc.com/peer-exchange/oncology-stakeholder-summit-spring-2015 2021-05-19 0.50 https://www.ajmc.com/peer-exchange/oncology-stakeholder-summit-spring-2016 2021-05-19 0.50 https://www.ajmc.com/peer-exchange/oncology-stakeholders-summit-fall-2016 2021-05-19 0.50 https://www.ajmc.com/peer-exchange/oncology-stakeholders-summit-spring-2017 2021-05-19 0.50 https://www.ajmc.com/peer-exchange/oncology-stakeholders-summit-summer-2018 2021-05-19 0.50 https://www.ajmc.com/peer-exchange/oral-oncolytics-exploring-challenges-in-cost-adherence-and-management 2021-05-19 0.50 https://www.ajmc.com/peer-exchange/overview-value-based-marketplace 2021-05-19 0.50 https://www.ajmc.com/peer-exchange/preventative-migraines 2021-05-19 0.50 https://www.ajmc.com/peer-exchange/prostatecancer 2021-05-19 0.50 https://www.ajmc.com/peer-exchange/rare-disease 2021-05-19 0.50 https://www.ajmc.com/peer-exchange/rare-neurological-diseases 2021-05-19 0.50 https://www.ajmc.com/peer-exchange/reducing-cardiovascular-mortality-in-patients-with-type-2-diabetes-mellitus 2021-05-19 0.50 https://www.ajmc.com/peer-exchange/reducing-cvd-risk-through-optimal-lipid-management 2021-05-19 0.50 https://www.ajmc.com/peer-exchange/review-of-treatment-for-multiple-myeloma 2021-05-19 0.50 https://www.ajmc.com/peer-exchange/schizophrenia-relapse-prevention 2021-05-19 0.50 https://www.ajmc.com/peer-exchange/sglt2-inhibitors-heart-failure 2021-05-19 0.50 https://www.ajmc.com/peer-exchange/special-considerations-in-hiv-management 2021-05-19 0.50 https://www.ajmc.com/peer-exchange/technology-in-diabetes-care-from-prevention-to-disease-management 2021-05-19 0.50 https://www.ajmc.com/peer-exchange/therapy-in-anemia-of-chronic-kidney-disease 2021-05-19 0.50 https://www.ajmc.com/peer-exchange/treatment-metastatic-breast-cancer 2021-05-19 0.50 https://www.ajmc.com/peer-exchange/treatment-of-bone-health 2021-05-19 0.50 https://www.ajmc.com/peer-exchange/reducing-alzheimers-disease-burden-through-early-diagnosis-and-treatment 2021-09-08 0.50 https://www.ajmc.com/peer-exchange/implications-of-expanding-use-of-car-t-cell-therapy-in-relapsed-refractory-non-hodgkin-lymphoma-nhl 2021-05-19 0.50 https://www.ajmc.com/peer-exchange/reducing-disease-burden-through-early-diagnosis-and-treatment-of-spinal-muscular-atrophy 2021-05-19 0.50 https://www.ajmc.com/peer-exchange/supporting-cross-benefit-management-of-infused-drugs 2021-05-19 0.50 https://www.ajmc.com/insights/optimizing-alopecia-areata-management-navigating-severity-treatment-selection-and-access 2026-04-29 0.50 https://www.ajmc.com/insights/management-of-acquired-thrombotic-thrombocytopenic-purpura 2021-08-20 0.50 https://www.ajmc.com/insights/evaluating-physician-and-payer-perspectives-in-the-management-of-hemophilia-a 2023-10-25 0.50 https://www.ajmc.com/insights/real-world-evidence-and-access-considerations-for-anti-vegf-therapies-in-retinal-vascular 2026-06-22 0.50 https://www.ajmc.com/insights/enhancing-patient-care-in-dlbcl-and-fl-insights-on-industry-provided-patient-support-services 2024-12-23 0.50 https://www.ajmc.com/insights/the-obesity-mash-connection-clinical-insights-from-the-2026-ada-scientific-sessions 2026-06-26 0.50 https://www.ajmc.com/insights/unveiling-disparities-fostering-awareness-and-building-inclusive-strategies-in-diabetic-macular 2023-11-28 0.50 https://www.ajmc.com/insights/eosinophilic-esophagitis-insights-provider-perspectives 2024-01-22 0.50 https://www.ajmc.com/insights/ash-2024-insights-optimizing-bispecific-antibody-therapy-in-relapsed-refractory-multiple-myeloma 2024-12-23 0.50 https://www.ajmc.com/insights/unmet-needs-and-future-treatments-of-idiopathic-pulmonary-fibrosis 2024-06-14 0.50 https://www.ajmc.com/insights/elevating-early-detection-transforming-crm-care-through-connected-system-wide-action 2026-07-29 0.50 https://www.ajmc.com/insights/follicular-lymphoma-in-focus-immunotherapy-across-care-settings 2026-06-10 0.50 https://www.ajmc.com/insights/overcoming-barriers-with-hiv-prep 2022-08-16 0.50 https://www.ajmc.com/insights/elevating-early-detection-transforming-mash-care-through-connected-system-wide-action 2026-05-20 0.50 https://www.ajmc.com/insights/precision-medicine-and-immunotherapy-in-mnsclc-bridging-gaps-for-patients-without-driver 2023-09-12 0.50 https://www.ajmc.com/insights/management-of-homozygous-familial-hypercholesterolemia-hofh 2022-12-21 0.50 https://www.ajmc.com/insights/treatment-perspectives-and-evolving-paradigms-in-rett-syndrome 2022-11-28 0.50 https://www.ajmc.com/insights/discussing-key-updates-in-the-management-of-patients-with-demodex-blepharitis 2023-12-06 0.50 https://www.ajmc.com/insights/multidisciplinary-approaches-to-paraneoplastic-lems-insights-for-healthcare-decision-makers 2024-12-04 0.50 https://www.ajmc.com/insights/advancing-cll-and-mcl-care-the-impact-of-btk-inhibitors-in-treatment-naive-patients-and-emerging 2024-12-20 0.50 https://www.ajmc.com/insights/exploring-novel-uses-for-prescription-digital-therapeutics-in-mental-health 2025-09-17 0.50 https://www.ajmc.com/insights/improving-her2-biomarker-testing-in-mcrc 2022-07-11 0.50 https://www.ajmc.com/insights/optimizing-management-of-lupus-nephritis 2022-11-18 0.50 https://www.ajmc.com/insights/pulmonary-arterial-hypertension-navigating-the-treatment-paradigm-emerging-therapies-and-health 2024-04-25 0.50 https://www.ajmc.com/insights/managing-advanced-stages-of-friedreich-s-ataxia-challenges-and-emerging-therapeutic-avenues 2025-05-22 0.50 https://www.ajmc.com/insights/the-role-and-value-of-prescription-digital-therapeutics-in-behavioral-disorders 2022-06-13 0.50 https://www.ajmc.com/insights/evolving-treatment-paradigms-in-upper-gi-cancer-insights-program 2022-10-11 0.50 https://www.ajmc.com/insights/exploring-a-chronic-and-painful-inflammatory-skin-disease 2024-06-13 0.50 https://www.ajmc.com/insights/evolving-insights-within-the-biosimilars-landscape-a-fireside-chat 2025-02-11 0.50 https://www.ajmc.com/insights/ajmc-insights-lupus-nephritis 2021-08-05 0.50 https://www.ajmc.com/insights/from-assessment-to-innovation-a-clinical-deep-dive-into-atopic-dermatitis 2026-06-29 0.50 https://www.ajmc.com/insights/reframing-disability-in-multiple-sclerosis-addressing-unmet-needs-beyond-relapse 2025-07-18 0.50 https://www.ajmc.com/insights/managing-mutations-in-non-small-cell-lung-cancer 2022-06-22 0.50 https://www.ajmc.com/insights/the-burden-of-bronchiectasis 2023-12-12 0.50 https://www.ajmc.com/insights/considerations-for-the-management-of-respiratory-syncytial-virus-rsv 2023-05-25 0.50 https://www.ajmc.com/insights/mitigating-cardiovascular-risk-through-effective-lipid-management 2022-04-07 0.50 https://www.ajmc.com/insights/advancing-ovarian-cancer-treatment-insights-from-emerging-therapies 2025-07-08 0.50 https://www.ajmc.com/insights/defining-value-with-a-changing-biosimilar-landscape 2022-07-29 0.50 https://www.ajmc.com/insights/advancements-in-population-health-strategies-for-cardiovascular-risk-management 2023-11-30 0.50 https://www.ajmc.com/insights/treatment-updates-in-recurrent-c-difficile-infections 2025-02-11 0.50 https://www.ajmc.com/insights/optimizing-the-transition-to-biosimilars-considerations-for-payers 2021-10-26 0.50 https://www.ajmc.com/insights/cardiovascular-risk-and-prostate-cancer-management 2021-12-20 0.50 https://www.ajmc.com/insights/beyond-platelet-counts-evaluating-clinical-challenges-and-treatment-approaches-for-patients-with-itp 2025-05-30 0.50 https://www.ajmc.com/insights/hidradenitis-suppurativa-insights-advancing-early-diagnosis-guideline-driven-care 2025-02-11 0.50 https://www.ajmc.com/insights/imids-in-relapsed-refractory-multiple-myeloma 2022-06-03 0.50 https://www.ajmc.com/insights/type-2-inflammation-a-common-theme-amongst-several-chronic-diseases 2024-07-31 0.50 https://www.ajmc.com/insights/bridging-guidelines-and-real-world-practice-in-iga-nephropathy 2026-02-05 0.50 https://www.ajmc.com/insights/key-immunologic-updates-in-patients-with-rheumatoid-arthritis 2026-07-30 0.50 https://www.ajmc.com/insights/eosinophilic-esophagitis-insights-caregiver-perspectives 2023-12-22 0.50 https://www.ajmc.com/insights/ada-insights-strategic-t1dm-screening-and-management 2024-04-04 0.50 https://www.ajmc.com/insights/heart-failure-with-preserved-ejection-fraction-current-status-and-future-opportunities 2022-02-18 0.50 https://www.ajmc.com/insights/chemotherapy-induced-neutropenia 2021-05-19 0.50 https://www.ajmc.com/insights/advances-in-the-treatment-of-hyperhidrosis 2021-05-19 0.50 https://www.ajmc.com/insights/ajmctv-insights-alternative-markers 2021-05-19 0.50 https://www.ajmc.com/insights/ajmctv-insights-cardio 2021-05-19 0.50 https://www.ajmc.com/insights/ajmctv-insights-companion-diagnostics 2021-05-19 0.50 https://www.ajmc.com/insights/ajmctv-insights-oncology 2021-05-19 0.50 https://www.ajmc.com/insights/ajmctv-insights-prostate-cancer 2021-05-19 0.50 https://www.ajmc.com/insights/antiangiogenic-therapy-in-nsclc 2021-05-19 0.50 https://www.ajmc.com/insights/biologics-treatment-adolescent-atopic-derm 2021-05-19 0.50 https://www.ajmc.com/insights/clinical-progress-and-coverage-policies-in-immuno-oncology 2021-05-19 0.50 https://www.ajmc.com/insights/clinical-reimbursement-landscape-immuno-oncology 2021-05-19 0.50 https://www.ajmc.com/insights/current-clinical-landscape-and-managed-care-approach-in-multiple-myeloma 2021-05-19 0.50 https://www.ajmc.com/insights/current-treatment-regimens-for-mm 2021-05-19 0.50 https://www.ajmc.com/insights/diagnostic-testing 2021-05-19 0.50 https://www.ajmc.com/insights/emerging-agents-for-basal-cell-carcinoma-and-cutaneous-squamous-cell-carcinoma 2021-05-19 0.50 https://www.ajmc.com/insights/emerging-therapies-ild 2021-05-19 0.50 https://www.ajmc.com/insights/employer-migraine 2021-05-19 0.50 https://www.ajmc.com/insights/employer-opportunities-with-biosimilars 2021-05-19 0.50 https://www.ajmc.com/insights/innovative-payment-models-in-oncology 2021-05-19 0.50 https://www.ajmc.com/insights/management-of-diabetic-retinopathy 2021-05-19 0.50 https://www.ajmc.com/insights/management-of-myelodysplastic-syndrome 2021-05-19 0.50 https://www.ajmc.com/insights/multiple-sclerosis-treatment-advances 2021-05-19 0.50 https://www.ajmc.com/insights/myelofibrosis-emerging-agents 2021-05-19 0.50 https://www.ajmc.com/insights/non-alcoholic-steotohepatitis 2021-05-19 0.50 https://www.ajmc.com/insights/nsclc-clinical-care 2021-05-19 0.50 https://www.ajmc.com/insights/parp-inhibitors-in-the-management-of-ovarian-cancer 2021-05-19 0.50 https://www.ajmc.com/insights/patient-selection-safety-tnf-inhibitors 2021-05-19 0.50 https://www.ajmc.com/insights/payer-perspectives-in-the-management-of-nonsmall-cell-lung-cancer 2021-05-19 0.50 https://www.ajmc.com/insights/personalized-selection-of-upfront-therapy-in-cll 2021-05-19 0.50 https://www.ajmc.com/insights/subpopulations-pulmonary-hypertension 2021-05-19 0.50 https://www.ajmc.com/insights/treatment-for-patients-with-thromboembolic-complications 2021-08-12 0.50 https://www.ajmc.com/insights/understanding-axial-spondyloarthritis 2021-05-19 0.50 https://www.ajmc.com/insights/updates-in-the-treatment-of-chronic-lymphocytic-leukemia 2021-05-19 0.50 https://www.ajmc.com/insights/updates-in-the-treatment-of-pulmonary-arterial-hypertension 2021-05-19 0.50 https://www.ajmc.com/insights/updates-management-t2dm-comorbid-dyslipidemia 2021-05-19 0.50 https://www.ajmc.com/insights/use-of-anticoagulants-to-prevent-stroke-in-nonvalvular-atrial-fibrillation 2021-05-19 0.50 https://www.ajmc.com/insights/use-of-oral-oncolytics-in-palliative-care 2021-05-19 0.50 https://www.ajmc.com/insights/car-t-cell-therapy-for-the-management-of-multiple-myeloma 2021-05-19 0.50 https://www.ajmc.com/insights/defining-value-for-the-treatment-of-brain-metastases-in-metastatic-her2-positive-breast-cancer 2021-05-19 0.50 https://www.ajmc.com/insights/challenges-and-opportunities-for-patients-with-hiv-during-covid-19 2021-05-19 0.50 https://www.ajmc.com/payer-perspectives/navigating-the-attr-cm-landscape-balancing-access-adoption-and-outcomes 2026-03-05 0.50 https://www.ajmc.com/payer-perspectives/payer-perspectives-in-major-depressive-disorder-mdd 2022-10-31 0.50 https://www.ajmc.com/payer-perspectives/respiratory-syncytial-virus-rsv-in-infants-and-children 2023-08-21 0.50 https://www.ajmc.com/payer-perspectives/topical-therapies-for-the-treatment-of-atopic-dermatitis-balancing-safety-efficacy-and-access 2024-06-24 0.50 https://www.ajmc.com/payer-perspectives/ajmc-payer-perspectives-collaborative-efforts-in-lupus-nephritis 2024-10-18 0.50 https://www.ajmc.com/payer-perspectives/examining-the-role-of-a-novel-class-of-medications-for-the-management-of-multiple-sclerosis 2024-06-14 0.50 https://www.ajmc.com/stakeholder-summit/cardiometabolic-health-and-systems-approach-to-risk-factor-modification 2024-10-21 0.50 https://www.ajmc.com/stakeholder-summit/new-treatment-landscape-in-ms-preventing-long-term-disability-through-high-efficacy-treatments-in-early-ms 2021-06-17 0.50 https://www.ajmc.com/stakeholder-summit/biosimilars-stakeholder-summit-interchangeable-biosimilars-in-inflammatory-diseases 2024-08-13 0.50 https://www.ajmc.com/stakeholder-summit/advancing-hepatic-encephalopathy-management 2024-08-14 0.50 https://www.ajmc.com/stakeholder-summit/unpacking-disparities-in-cardiovascular-disease-management-exploring-strategies-for-equitable 2024-02-28 0.50 https://www.ajmc.com/stakeholder-summit/addressing-disparities-in-women-s-health-equity 2023-05-04 0.50 https://www.ajmc.com/stakeholder-summit/advancing-diabetes-care-the-future-of-continuous-glucose-monitoring-in-the-management-of 2025-03-17 0.50 https://www.ajmc.com/stakeholder-summit/chronic-kidney-disease-stakeholder-summit 2023-09-13 0.50 https://www.ajmc.com/stakeholder-summit/treating-psoriasis-across-all-skin-phototypes-stakeholder-summit 2023-05-04 0.50 https://www.ajmc.com/stakeholder-summit/making-ldl-matter-again-addressing-clinical-patient-and-payer-barriers-in-ascvd-management 2025-10-22 0.50 https://www.ajmc.com/stakeholder-summit/preventing-clinical-inertia-in-early-treatment-management-of-type-2-diabetes 2022-12-13 0.50 https://www.ajmc.com/stakeholder-summit/transforming-pulmonary-arterial-hypertension-management-bridging-clinical-practice-innovative 2025-06-10 0.50 https://www.ajmc.com/stakeholder-summit/putting-the-enhancing-oncology-model-into-practice 2025-05-23 0.50 https://www.ajmc.com/stakeholder-summit/optimizing-dry-eye-disease-management-exploring-unmet-treatment-needs 2023-11-29 0.50 https://www.ajmc.com/stakeholder-summit/copd-stakeholder-summit-utilizing-peak-inspiratory-flow-rates-to-individualize-treatment-and-improve-outcomes 2022-02-18 0.50 https://www.ajmc.com/podcasts/managed-care-cast 2026-07-10 0.50 https://www.ajmc.com/guidelines 2026-07-01 0.50 https://www.ajmc.com/post-conference-perspectives 2026-07-01 0.50